Search company, investor...

About Cosmo S.p.A.

Cosmo S.p.A. focuses on developing innovative treatments for unmet medical needs in the fields of gastroenterology, dermatology, and healthtech. The company offers a range of pharmaceutical products and medical devices aimed at improving gastrointestinal health, treating skin conditions, and enhancing the effectiveness of endoscopic examinations. Cosmo also provides pharmaceutical manufacturing services, including process assessment, technology transfer, and product stability evaluation. It is based in Italy.

Headquarters Location

Cosmo Pharmaceuticals S.p.A. Via C. Colombo 1

20020,

Italy

Loading...

Loading...

Cosmo S.p.A. Patents

Cosmo S.p.A. has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2013

9/6/2016

Glucocorticoids, Pregnanes, Diketones, Corticosteroid esters, Corticosteroids

Grant

Application Date

11/7/2013

Grant Date

9/6/2016

Title

Related Topics

Glucocorticoids, Pregnanes, Diketones, Corticosteroid esters, Corticosteroids

Status

Grant

Cosmo S.p.A. Frequently Asked Questions (FAQ)

  • Who are Cosmo S.p.A.'s competitors?

    Competitors of Cosmo S.p.A. include Humanetics, Intarcia Therapeutics, Actinobac Biomed, TARIS Biomedical - LiRIS, Altheus Therapeutics and 7 more.

Loading...

Compare Cosmo S.p.A. to Competitors

A
Antipodean

Antipodean is a pharmaceutical company developing treatments for neurodegenerative diseases such as Parkinson's Disease and Friedreich's Ataxia that are associated with mitochondrial dysfunction.

I
Intarcia Therapeutics

Intarcia Therapeutics operates as a biopharmaceutical company. The company develops and commercializes therapies to transform the prevention and management of chronic diseases. The company was founded in 1995 and is based in Boston, Massachusetts.

H
Humanetics

Humanetics is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and well-being in markets with urgent and unmet needs. It has a focus on radiation modulators for oncology, medical imaging, and medical countermeasure uses. The company develops BIO 300, a selective modulator of inflammation, cell cycle arrest, and DNA damage repair. Humanetics was founded in 1988 and is based in Minneapolis, Minnesota.

E
Embera NeuroTherapeutics

Embera NeuroTherapeutics is a clinical-stage pharmaceutical company focused on developing novel treatments for addiction. Their main product, EMB-001, is designed to reduce cravings and loss of control in individuals by targeting multiple pathways in the stress response system. The company's research primarily addresses the unmet medical needs in the treatment of cocaine use disorder and smoking cessation. It was founded in 2005 and is based in Sudbury, Massachusetts.

CoImmune Logo
CoImmune

CoImmune is a company that focuses on the development and manufacture of cell-based therapeutics, operating within the healthcare and biotechnology sectors. The company's main offerings include treatments for unmet medical needs such as cancer, autoimmune, and inflammatory diseases. It was founded in 1997 and is based in Durham, North Carolina. CoImmune operates as a subsidiary of Genexine and SCM Lifescience.

C
Calyx Therapeutics

Calyx Therapeutics is a pharmaceutical company focusing on oral therapies for diabetes and inflammatory diseases. Calyx utilizes natural plant extracts with demonstrated clinical activity in humans as the source of its discovery efforts. The company isolates the biologically active molecule, determines its chemical structure, and aims to develop small molecule analogs. This process aims to reduce the time and investment required to take lead molecules into preclinical and clinical testing.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.